Because ILC in general lacks expression of human epidermal growth factor receptor 2 (Her2; a marker present in some breast cancer subtypes for which specific treatments are available), there is currently no targeted intervention for metastatic lobular breast cancer. Here, ERBB2 is linked to breast cancer.